Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
Argenx BVBA
Start Date
February 24, 2021
End Date
May 20, 2022
Administered By
Neurology, Neuromuscular Disease
Awarded By
Argenx BVBA
Start Date
February 24, 2021
End Date
May 20, 2022